Evidence Based Medicine presented by InpharmD™

This week, we look at two different case reports:

1) Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

2) Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination

Tune in to learn more!

A cohort study conducted to determine whether there is a dose–response relationship between the intensity of exposure to the World Trade Center (WTC) site and the risk of hepatic steatosis (HS) in the WTC General Responder Cohort (GRC).

A prospective, multi-center, international cohort study conducted to evaluate the relation between intake of ultra-processed food and risk of inflammatory bowel disease (IBD), Crohn's Disease, and Ulcerative Colitis.

A double-blind, placebo-controlled, cross-over study conducted to assess the impact of childhood trauma on responses to morphine and pain processing.

A study that use supervised machine learning to identify potential variables important to assessing risk of incident chronic heart disease (CHD), stroke, and heart failure (HF) in a hypothesis-free, data-driven manner.

A study conducted to investigate the acceptability and tolerability of an intra-oral device, designed to facilitate weight loss

Here we provide an overview of three case reports focusing on patients who developed rhino-orbital mucormycosis, a rare fungal infection, potentially from COVID-19.

A multicenter, randomized, open-label, parallel-group trial conducted to determine the effectiveness of continuous glucose monitoring (CGM) in adults with type 2 diabetes treated with basal insulin.

An international, randomized, double-blind, placebo-controlled trial conducted to evaluate the efficacy and safety of semaglutide, as compared with placebo, as an adjunct to lifestyle intervention for reducing body weight in overweight and obese adults without diabetes.

An investigator-initiated, multicenter, parallel-group, open-label, randomized clinical trial conducted to determine whether continuous infusion of hypertonic saline solution improves neurological outcomes at 6 months in patients with traumatic brain injury